BRIDGEBIO PHARMA INC (BBIO) Institutional Ownership Changes & 13F Activity

BRIDGEBIO PHARMA INC (BBIO). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings. This page analyzes institutional buying and selling activity, new holdings, and sold-out positions among tracked filers. Notable filers include Viking Global Investors, Renaissance Technologies LLC, Polen Capital Management, and Sequoia Financial Advisors.

Portfolio quarterNameTypeQuantityRemainingReported stock balance
Q1 2026Viking Global InvestorsSell-2,551,50011,842,434$879,419,149
Q1 2026Renaissance Technologies LLCBuy43,526365,772$27,162,229
Q1 2026Polen Capital ManagementBuy7,69345,934$3,411,059
Q4 2025Viking Global InvestorsSell-1,583,91514,393,934$1,100,992,012
Q4 2025Sequoia Financial AdvisorsBuy3,1343,134$239,720
Q4 2025Polen Capital ManagementBuy2,07738,241$2,925,054
Q3 2025Viking Global InvestorsSell-2,577,52615,977,849$829,889,477
Q3 2025Renaissance Technologies LLCBuy76,300322,246$16,737,457
Q3 2025Polen Capital ManagementBuy51536,164$1,878,358
Q2 2025Viking Global InvestorsSell-3,500,00018,555,375$801,221,093
Q2 2025Renaissance Technologies LLCSell-338,200245,946$10,619,948
Q2 2025Polen Capital ManagementBuy35,64935,649$1,539,324
Q1 2025Viking Global InvestorsSell-3,065,61622,055,375$762,454,314
Q3 2023Viking Global InvestorsSell-1,500,00025,120,991$662,440,533
Q3 2023Renaissance Technologies LLCSell-179,600584,146$15,404
Q1 2023Renaissance Technologies LLCSell-266,200763,746$12,663
Q4 2022Renaissance Technologies LLCSell-336,8001,029,946$7,848
Q3 2022Renaissance Technologies LLCBuy953,5001,366,746$13,585
Q2 2022Renaissance Technologies LLCBuy294,700413,246$3,752
Q1 2021Renaissance Technologies LLCBuy118,546118,546$7,302
Q2 2019Viking Global InvestorsBuy26,620,99126,620,991$717,968

Frequently asked questions about BBIO activity

  • Which institutional owners are buying BBIO?

    Institutional owners buying BBIO include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in BBIO activity?

    "Buy" means an investor increased their reported position in BBIO compared to the prior reporting period. This reflects growing exposure to BRIDGEBIO PHARMA INC (BBIO) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in BBIO increasing?

    Institutional interest in BBIO can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.

Related BBIO Institutional Insights